Series A Biotechnology Companies

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.

Vima Therapeutics operates as a biotechnology company.

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

Cosomil is a pharmaceutical company that offers research and develops methods for diagnosing early-stage diseases, including cancer.

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Starget Pharma develops a novel somatostatin-based targeted therapy platform.

PACT designs Elegant materials produced in tune with the planet earth.

Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.

Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.

Weave Bio is an AI-native platform transforming regulatory workflows and accelerating how novel therapies reach patients faster.

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment.

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

Singletto develops novel antimicrobial solutions and singlet oxygen technology to protect against pathogens.

Phagos develops personalised bacteriophage solutions as a sustainable alternative to antibiotics

Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

AiM Medical Robotics is a biotechnology company developing a robotic system for use in neurosurgical procedures.

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

StemInov develops stem cell therapies for inflammatory diseases, focusing on septic shock and ARDS.